Industry: Medical Devices & Consumables
Published Date: 2026-04-17
Pages: 118 Pages
Report ld: 6471920
Request Sample
Customized Report
The global Particle Therapy Systems market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Particle Therapy Systems competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Particle Therapy Systems is a kind of external beam radiotherapy that uses positively charged particles such as protons and carbon ions instead of photons.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report delivers a comprehensive overview of the global Particle Therapy Systems market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Particle Therapy Systems. The Particle Therapy Systems market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Particle Therapy Systems market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Particle Therapy Systems manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Particle Therapy Systems manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Particle Therapy Systems sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Particle Therapy Systems Market Overview
1.1 Product Definition
1.2 Particle Therapy Systems by Type
1.2.1 Global Particle Therapy Systems Market Value by Type: 2025 vs 2032
1.2.2 Cyclotrons
1.2.3 Synchrotrons
1.2.4 Synchrocyclotron
1.3 Particle Therapy Systems by Application
1.3.1 Global Particle Therapy Systems Market Value by Application: 2025 vs 2032
1.3.2 External Beam Radiotherapy
1.3.3 Internal Beam Radiotherapy/Brachytherapy
1.4 Global Particle Therapy Systems Market Size Estimates and Forecasts
1.4.1 Global Particle Therapy Systems Revenue 2021–2032
1.4.2 Global Particle Therapy Systems Sales 2021–2032
1.4.3 Global Particle Therapy Systems Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Particle Therapy Systems Market Competition by Manufacturers
2.1 Global Particle Therapy Systems Sales Market Share by Manufacturers (2021–2026)
2.2 Global Particle Therapy Systems Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Particle Therapy Systems Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Particle Therapy Systems, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Particle Therapy Systems, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Particle Therapy Systems, Product Types and Applications
2.7 Global Key Manufacturers of Particle Therapy Systems, Date of Entry into the Industry
2.8 Global Particle Therapy Systems Market Competitive Situation and Trends
2.8.1 Global Particle Therapy Systems Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Particle Therapy Systems Players Market Share by Revenue
2.8.3 Global Particle Therapy Systems Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Particle Therapy Systems Market Scenario by Region
3.1 Global Particle Therapy Systems Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Particle Therapy Systems Sales by Region: 2021–2032
3.2.1 Global Particle Therapy Systems Sales by Region: 2021–2026
3.2.2 Global Particle Therapy Systems Sales by Region: 2027–2032
3.3 Global Particle Therapy Systems Revenue by Region: 2021–2032
3.3.1 Global Particle Therapy Systems Revenue by Region: 2021–2026
3.3.2 Global Particle Therapy Systems Revenue by Region: 2027–2032
3.4 North America Particle Therapy Systems Market Facts & Figures by Country
3.4.1 North America Particle Therapy Systems Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Particle Therapy Systems Sales by Country (2021–2032)
3.4.3 North America Particle Therapy Systems Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Particle Therapy Systems Market Facts & Figures by Country
3.5.1 Europe Particle Therapy Systems Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Particle Therapy Systems Sales by Country (2021–2032)
3.5.3 Europe Particle Therapy Systems Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Particle Therapy Systems Market Facts & Figures by Region
3.6.1 Asia Pacific Particle Therapy Systems Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Particle Therapy Systems Sales by Region (2021–2032)
3.6.3 Asia Pacific Particle Therapy Systems Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Particle Therapy Systems Market Facts & Figures by Country
3.7.1 Latin America Particle Therapy Systems Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Particle Therapy Systems Sales by Country (2021–2032)
3.7.3 Latin America Particle Therapy Systems Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Particle Therapy Systems Market Facts & Figures by Country
3.8.1 Middle East and Africa Particle Therapy Systems Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Particle Therapy Systems Sales by Country (2021–2032)
3.8.3 Middle East and Africa Particle Therapy Systems Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Particle Therapy Systems Sales by Type (2021–2032)
4.1.1 Global Particle Therapy Systems Sales by Type (2021–2026)
4.1.2 Global Particle Therapy Systems Sales by Type (2027–2032)
4.1.3 Global Particle Therapy Systems Sales Market Share by Type (2021–2032)
4.2 Global Particle Therapy Systems Revenue by Type (2021–2032)
4.2.1 Global Particle Therapy Systems Revenue by Type (2021–2026)
4.2.2 Global Particle Therapy Systems Revenue by Type (2027–2032)
4.2.3 Global Particle Therapy Systems Revenue Market Share by Type (2021–2032)
4.3 Global Particle Therapy Systems Price by Type (2021–2032)
5 Segment by Application
5.1 Global Particle Therapy Systems Sales by Application (2021–2032)
5.1.1 Global Particle Therapy Systems Sales by Application (2021–2026)
5.1.2 Global Particle Therapy Systems Sales by Application (2027–2032)
5.1.3 Global Particle Therapy Systems Sales Market Share by Application (2021–2032)
5.2 Global Particle Therapy Systems Revenue by Application (2021–2032)
5.2.1 Global Particle Therapy Systems Revenue by Application (2021–2026)
5.2.2 Global Particle Therapy Systems Revenue by Application (2027–2032)
5.2.3 Global Particle Therapy Systems Revenue Market Share by Application (2021–2032)
5.3 Global Particle Therapy Systems Price by Application (2021–2032)
6 Key Companies Profiled
6.1 IBA
6.1.1 IBA Company Information
6.1.2 IBA Description and Business Overview
6.1.3 IBA Particle Therapy Systems Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 IBA Particle Therapy Systems Product Portfolio
6.1.5 IBA Recent Developments/Updates
6.2 ViewRay Technologies
6.2.1 ViewRay Technologies Company Information
6.2.2 ViewRay Technologies Description and Business Overview
6.2.3 ViewRay Technologies Particle Therapy Systems Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 ViewRay Technologies Particle Therapy Systems Product Portfolio
6.2.5 ViewRay Technologies Recent Developments/Updates
6.3 Hitachi
6.3.1 Hitachi Company Information
6.3.2 Hitachi Description and Business Overview
6.3.3 Hitachi Particle Therapy Systems Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Hitachi Particle Therapy Systems Product Portfolio
6.3.5 Hitachi Recent Developments/Updates
6.4 iCAD
6.4.1 iCAD Company Information
6.4.2 iCAD Description and Business Overview
6.4.3 iCAD Particle Therapy Systems Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 iCAD Particle Therapy Systems Product Portfolio
6.4.5 iCAD Recent Developments/Updates
6.5 IsoRay
6.5.1 IsoRay Company Information
6.5.2 IsoRay Description and Business Overview
6.5.3 IsoRay Particle Therapy Systems Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 IsoRay Particle Therapy Systems Product Portfolio
6.5.5 IsoRay Recent Developments/Updates
6.6 Mevion Medical Systems
6.6.1 Mevion Medical Systems Company Information
6.6.2 Mevion Medical Systems Description and Business Overview
6.6.3 Mevion Medical Systems Particle Therapy Systems Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Mevion Medical Systems Particle Therapy Systems Product Portfolio
6.6.5 Mevion Medical Systems Recent Developments/Updates
6.7 Panacea Medical Technologies
6.7.1 Panacea Medical Technologies Company Information
6.7.2 Panacea Medical Technologies Description and Business Overview
6.7.3 Panacea Medical Technologies Particle Therapy Systems Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Panacea Medical Technologies Particle Therapy Systems Product Portfolio
6.7.5 Panacea Medical Technologies Recent Developments/Updates
6.8 P-cure
6.8.1 P-cure Company Information
6.8.2 P-cure Description and Business Overview
6.8.3 P-cure Particle Therapy Systems Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 P-cure Particle Therapy Systems Product Portfolio
6.8.5 P-cure Recent Developments/Updates
6.9 ZEISS Group
6.9.1 ZEISS Group Company Information
6.9.2 ZEISS Group Description and Business Overview
6.9.3 ZEISS Group Particle Therapy Systems Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 ZEISS Group Particle Therapy Systems Product Portfolio
6.9.5 ZEISS Group Recent Developments/Updates
6.10 Siemens
6.10.1 Siemens Company Information
6.10.2 Siemens Description and Business Overview
6.10.3 Siemens Particle Therapy Systems Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Siemens Particle Therapy Systems Product Portfolio
6.10.5 Siemens Recent Developments/Updates
6.11 Elekta
6.11.1 Elekta Company Information
6.11.2 Elekta Description and Business Overview
6.11.3 Elekta Particle Therapy Systems Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Elekta Particle Therapy Systems Product Portfolio
6.11.5 Elekta Recent Developments/Updates
6.12 Accuray Incorporated
6.12.1 Accuray Incorporated Company Information
6.12.2 Accuray Incorporated Description and Business Overview
6.12.3 Accuray Incorporated Particle Therapy Systems Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Accuray Incorporated Particle Therapy Systems Product Portfolio
6.12.5 Accuray Incorporated Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Particle Therapy Systems Industry Chain Analysis
7.2 Particle Therapy Systems Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Particle Therapy Systems Production Mode & Process Analysis
7.4 Particle Therapy Systems Sales and Marketing
7.4.1 Particle Therapy Systems Sales Channels
7.4.2 Particle Therapy Systems Distributors
7.5 Particle Therapy Systems Customer Analysis
8 Particle Therapy Systems Market Dynamics
8.1 Particle Therapy Systems Industry Trends
8.2 Particle Therapy Systems Market Drivers
8.3 Particle Therapy Systems Market Challenges
8.4 Particle Therapy Systems Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Particle Therapy Systems was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-06-16
Pages: 145
USD 3950.00
(Single User License)
The global Particle Therapy Systems market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 98
USD 4250.00
(Single User License)
The global Particle Therapy Systems market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-02
Pages: 170
USD 4900.00
(Single User License)
The global market for Particle Therapy Systems was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 124
USD 3950.00
(Single User License)
The global market for Particle Therapy Systems was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-01-13
Pages: 91
USD 2900.00
(Single User License)
Particle Therapy Systems is a kind of external beam radiotherapy that uses positively charged particles such as protons and carbon ions instead of photons.
Published Date: 2024-04-10
Pages: 111
USD 4900.00
(Single User License)
Particle Therapy Systems is a kind of external beam radiotherapy that uses positively charged particles such as protons and carbon ions instead of photons.
Published Date: 2024-01-17
Pages: 89
USD 2900.00
(Single User License)
The global market for Particle Therapy Systems was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-06-16
Pages: 145
The global Particle Therapy Systems market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 98
The global Particle Therapy Systems market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-02
Pages: 170
The global market for Particle Therapy Systems was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 124
The global market for Particle Therapy Systems was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-01-13
Pages: 91
Particle Therapy Systems is a kind of external beam radiotherapy that uses positively charged particles such as protons and carbon ions instead of photons.
Published: 2024-04-10
Pages: 111
Particle Therapy Systems is a kind of external beam radiotherapy that uses positively charged particles such as protons and carbon ions instead of photons.
Published: 2024-01-17
Pages: 89
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now